{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T11:39:47Z","timestamp":1791632387652,"version":"4.3.4"},"reference-count":85,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T00:00:00Z","timestamp":1663200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T00:00:00Z","timestamp":1663200000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"JSPS KAKENHI","award":["20K08651"],"award-info":[{"award-number":["20K08651"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Clin Dermatol"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1007\/s40257-022-00728-6","type":"journal-article","created":{"date-parts":[[2022,9,15]],"date-time":"2022-09-15T12:07:36Z","timestamp":1663243656000},"page":"41-54","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Cholinergic Urticaria: Subtype Classification and Clinical Approach"],"prefix":"10.1007","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2026-8154","authenticated-orcid":false,"given":"Atsushi","family":"Fukunaga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5244-0871","authenticated-orcid":false,"given":"Yoshiko","family":"Oda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8670-4997","authenticated-orcid":false,"given":"Shinya","family":"Imamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8530-1720","authenticated-orcid":false,"given":"Mayuko","family":"Mizuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0364-711X","authenticated-orcid":false,"given":"Takeshi","family":"Fukumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2468-7535","authenticated-orcid":false,"given":"Ken","family":"Washio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,15]]},"reference":[{"key":"728_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1001\/jama.1924.02660010007002","volume":"83","author":"WW Duke","year":"1924","unstructured":"Duke WW. Urticaria caused specifically by the action of physical agents. J Am Med Assoc. 1924;83:3\u20139.","journal-title":"J Am Med Assoc"},{"issue":"4","key":"728_CR2","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1001\/archderm.1987.01660280064024","volume":"123","author":"JV Hirschmann","year":"1987","unstructured":"Hirschmann JV, Lawlor F, English JS, Louback JB, Winkelmann RK, Greaves MW. Cholinergic urticaria: a clinical and histologic study. Arch Dermatol. 1987;123(4):462\u20137.","journal-title":"Arch Dermatol"},{"issue":"12","key":"728_CR3","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1111\/j.1365-2133.1968.tb11948.x","volume":"80","author":"M Moore-Robinson","year":"1968","unstructured":"Moore-Robinson M, Warin RP. Some clinical aspects of cholinergic urticaria. Br J Dermatol. 1968;80(12):794\u20139.","journal-title":"Br J Dermatol"},{"key":"728_CR4","unstructured":"Zuberbier T, Abdul Latiff AH, Abuzakouk M, Aquilina S, Asero R, Baker D, et al. The international EAACI\/GA(2)LEN\/EuroGuiDerm\/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria. Allergy. 2021."},{"issue":"6","key":"728_CR5","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/S0190-9622(94)70267-5","volume":"31","author":"T Zuberbier","year":"1994","unstructured":"Zuberbier T, Althaus C, Chantraine-Hess S, Czarnetzki BM. Prevalence of cholinergic urticaria in young adults. J Am Acad Dermatol. 1994;31(6):978\u201381.","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"728_CR6","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1111\/all.12884","volume":"71","author":"M Magerl","year":"2016","unstructured":"Magerl M, Altrichter S, Borzova E, Gimenez-Arnau A, Grattan CE, Lawlor F, et al. The definition, diagnostic testing, and management of chronic inducible urticarias: the EAACI\/GA(2) LEN\/EDF\/UNEV consensus recommendations 2016 update and revision. Allergy. 2016;71(6):780\u2013802.","journal-title":"Allergy"},{"issue":"10","key":"728_CR7","first-page":"1181","volume":"68","author":"A Fukunaga","year":"2019","unstructured":"Fukunaga A. Japanese guidelines for diagnosis and treatment of urticaria 2018. Arerugi. 2019;68(10):1181\u20137.","journal-title":"Arerugi"},{"issue":"2","key":"728_CR8","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.jdermsci.2016.02.001","volume":"82","author":"M Hatakeyama","year":"2016","unstructured":"Hatakeyama M, Fukunaga A, Washio K, Ogura K, Yamada Y, Horikawa T, et al. Addition of lafutidine can improve disease activity and lead to better quality of life in refractory cholinergic urticaria unresponsive to histamine H1 antagonists. J Dermatol Sci. 2016;82(2):137\u20139.","journal-title":"J Dermatol Sci"},{"issue":"11","key":"728_CR9","doi-asserted-by":"publisher","first-page":"2683","DOI":"10.1038\/jid.2010.188","volume":"130","author":"Y Sawada","year":"2010","unstructured":"Sawada Y, Nakamura M, Bito T, Fukamachi S, Kabashima R, Sugita K, et al. Cholinergic urticaria: studies on the muscarinic cholinergic receptor M3 in anhidrotic and hypohidrotic skin. J Invest Dermatol. 2010;130(11):2683\u20136.","journal-title":"J Invest Dermatol"},{"issue":"2","key":"728_CR10","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1111\/bjd.13285","volume":"172","author":"A Fukunaga","year":"2015","unstructured":"Fukunaga A, Hatakeyama M, Tsujimoto M, Oda Y, Washio K, Nishigori C. Steroid treatment can improve the impaired quality of life of patients with acquired idiopathic generalized anhidrosis. Br J Dermatol. 2015;172(2):537\u20138.","journal-title":"Br J Dermatol"},{"issue":"4","key":"728_CR11","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1111\/cea.13102","volume":"48","author":"J Ruft","year":"2018","unstructured":"Ruft J, Asady A, Staubach P, Casale T, Sussmann G, Zuberbier T, et al. Development and validation of the Cholinergic Urticaria Quality-of-Life Questionnaire (CholU-QoL). Clin Exp Allergy. 2018;48(4):433\u201344.","journal-title":"Clin Exp Allergy"},{"issue":"9","key":"728_CR12","doi-asserted-by":"publisher","first-page":"e493","DOI":"10.1111\/jdv.16410","volume":"34","author":"M Mizuno","year":"2020","unstructured":"Mizuno M, Fukunaga A, Washio K, Imamura S, Oda Y, Nishigori C. A visual analogue scale for itch and pain in 23 cases of cholinergic urticaria. J Eur Acad Dermatol Venereol. 2020;34(9):e493\u20135.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"728_CR13","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/S0091-6749(81)90209-8","volume":"68","author":"AP Kaplan","year":"1981","unstructured":"Kaplan AP, Garofalo J. Identification of a new physically induced urticaria: cold-induced cholinergic urticaria. J Allergy Clin Immunol. 1981;68(6):438\u201341.","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"728_CR14","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1111\/j.1365-2133.1981.tb00797.x","volume":"105","author":"CM Lawrence","year":"1981","unstructured":"Lawrence CM, Jorizzo JL, Kobza-Black A, Coutts A, Greaves MW. Cholinergic urticaria with associated angio-oedema. Br J Dermatol. 1981;105(5):543\u201350.","journal-title":"Br J Dermatol"},{"issue":"2","key":"728_CR15","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.jaip.2015.09.021","volume":"4","author":"P Vadas","year":"2016","unstructured":"Vadas P, Sinilaite A, Chaim M. Cholinergic urticaria with anaphylaxis: an underrecognized clinical entity. J Allergy Clin Immunol Pract. 2016;4(2):284\u201391.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"728_CR16","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1016\/j.jaip.2018.10.013","volume":"7","author":"EJ Mellerowicz","year":"2019","unstructured":"Mellerowicz EJ, Asady A, Maurer M, Altrichter S. Angioedema frequently occurs in cholinergic urticaria. J Allergy Clin Immunol Pract. 2019;7(4):1355-7.e1.","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"2","key":"728_CR17","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.jdermsci.2016.11.001","volume":"85","author":"K Washio","year":"2017","unstructured":"Washio K, Fukunaga A, Onodera M, Hatakeyama M, Taguchi K, Ogura K, et al. Clinical characteristics in cholinergic urticaria with palpebral angioedema: report of 15 cases. J Dermatol Sci. 2017;85(2):135\u20137.","journal-title":"J Dermatol Sci"},{"issue":"2","key":"728_CR18","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.alit.2014.12.004","volume":"64","author":"Y Oda","year":"2015","unstructured":"Oda Y, Fukunaga A, Tsujimoto M, Hatakeyama M, Washio K, Nishigori C. Combined cholinergic urticaria and cold-induced cholinergic urticaria with acquired idiopathic generalized anhidrosis. Allergol Int. 2015;64(2):214\u20135.","journal-title":"Allergol Int"},{"issue":"4","key":"728_CR19","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s11882-009-0038-x","volume":"9","author":"T Horikawa","year":"2009","unstructured":"Horikawa T, Fukunaga A, Nishigori C. New concepts of hive formation in cholinergic urticaria. Curr Allergy Asthma Rep. 2009;9(4):273\u20139.","journal-title":"Curr Allergy Asthma Rep"},{"issue":"1","key":"728_CR20","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1111\/j.1468-3083.2011.04017.x","volume":"26","author":"S Nakamizo","year":"2012","unstructured":"Nakamizo S, Egawa G, Miyachi Y, Kabashima K. Cholinergic urticaria: pathogenesis-based categorization and its treatment options. J Eur Acad Dermatol Venereol. 2012;26(1):114\u20136.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"728_CR21","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s10286-017-0418-6","volume":"28","author":"A Fukunaga","year":"2018","unstructured":"Fukunaga A, Washio K, Hatakeyama M, Oda Y, Ogura K, Horikawa T, et al. Cholinergic urticaria: epidemiology, physiopathology, new categorization, and management. Clin Auton Res. 2018;28(1):103\u201313.","journal-title":"Clin Auton Res"},{"issue":"1","key":"728_CR22","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jdermsci.2021.05.001","volume":"103","author":"S Altrichter","year":"2021","unstructured":"Altrichter S, Wang Y, Schumacher P, Alraboni O, Church MK, Maurer M. Acetylcholine-induced whealing in cholinergic urticaria: what does it tell us? J Dermatol Sci. 2021;103(1):10\u20135.","journal-title":"J Dermatol Sci"},{"issue":"4","key":"728_CR23","doi-asserted-by":"publisher","first-page":"539","DOI":"10.2332\/allergolint.12-RAI-0485","volume":"61","author":"T Bito","year":"2012","unstructured":"Bito T, Sawada Y, Tokura Y. Pathogenesis of cholinergic urticaria in relation to sweating. Allergol Int. 2012;61(4):539\u201344.","journal-title":"Allergol Int"},{"issue":"2","key":"728_CR24","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.jaci.2005.05.024","volume":"116","author":"A Fukunaga","year":"2005","unstructured":"Fukunaga A, Bito T, Tsuru K, Oohashi A, Yu X, Ichihashi M, et al. Responsiveness to autologous sweat and serum in cholinergic urticaria classifies its clinical subtypes. J Allergy Clin Immunol. 2005;116(2):397\u2013402.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"728_CR25","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/jid.2013.244","volume":"134","author":"Y Sawada","year":"2014","unstructured":"Sawada Y, Nakamura M, Bito T, Sakabe J, Kabashima-Kubo R, Hino R, et al. Decreased expression of acetylcholine esterase in cholinergic urticaria with hypohidrosis or anhidrosis. J Invest Dermatol. 2014;134(1):276\u20139.","journal-title":"J Invest Dermatol"},{"issue":"8","key":"728_CR26","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1212\/01.WNL.0000142036.54112.57","volume":"63","author":"Y Nakazato","year":"2004","unstructured":"Nakazato Y, Tamura N, Ohkuma A, Yoshimaru K, Shimazu K. Idiopathic pure sudomotor failure: anhidrosis due to deficits in cholinergic transmission. Neurology. 2004;63(8):1476\u201380.","journal-title":"Neurology"},{"issue":"11","key":"728_CR27","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1111\/1346-8138.13951","volume":"44","author":"S Iijima","year":"2017","unstructured":"Iijima S, Kojo K, Takayama N, Hiragun M, Kan T, Hide M. Case of cholinergic urticaria accompanied by anaphylaxis. J Dermatol. 2017;44(11):1291\u20134.","journal-title":"J Dermatol"},{"issue":"7","key":"728_CR28","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1016\/j.jaip.2020.01.025","volume":"8","author":"M Geller","year":"2020","unstructured":"Geller M. Clinical management of exercise-induced anaphylaxis and cholinergic urticaria. J Allergy Clin Immunol Pract. 2020;8(7):2209\u201314.","journal-title":"J Allergy Clin Immunol Pract"},{"key":"728_CR29","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1159\/000446787","volume":"51","author":"Y Tokura","year":"2016","unstructured":"Tokura Y. New etiology of cholinergic urticaria. Curr Probl Dermatol. 2016;51:94\u2013100.","journal-title":"Curr Probl Dermatol"},{"key":"728_CR30","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1111\/1346-8138.13649","volume":"44","author":"T Munetsugu","year":"2016","unstructured":"Munetsugu T, Fujimoto T, Oshima Y, Sano K, Murota H, Satoh T, et al. Revised guideline for the diagnosis and treatment of acquired idiopathic generalized anhidrosis in Japan. J Dermatol. 2016;44:394\u2013400.","journal-title":"J Dermatol"},{"issue":"2","key":"728_CR31","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/0923-1811(94)90088-4","volume":"7","author":"J Adachi","year":"1994","unstructured":"Adachi J, Aoki T, Yamatodani A. Demonstration of sweat allergy in cholinergic urticaria. J Dermatol Sci. 1994;7(2):142\u20139.","journal-title":"J Dermatol Sci"},{"issue":"2","key":"728_CR32","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1111\/j.1365-2133.2008.08862.x","volume":"160","author":"S Takahagi","year":"2009","unstructured":"Takahagi S, Tanaka T, Ishii K, Suzuki H, Kameyoshi Y, Shindo H, et al. Sweat antigen induces histamine release from basophils of patients with cholinergic urticaria associated with atopic diathesis. Br J Dermatol. 2009;160(2):426\u20138.","journal-title":"Br J Dermatol"},{"issue":"3","key":"728_CR33","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1016\/j.jaci.2013.03.047","volume":"132","author":"T Hiragun","year":"2013","unstructured":"Hiragun T, Ishii K, Hiragun M, Suzuki H, Kan T, Mihara S, et al. Fungal protein MGL_1304 in sweat is an allergen for atopic dermatitis patients. J Allergy Clin Immunol. 2013;132(3):608-15.e4.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"728_CR34","doi-asserted-by":"publisher","first-page":"83","DOI":"10.2332\/allergolint.13-OA-0611","volume":"63","author":"M Hiragun","year":"2014","unstructured":"Hiragun M, Hiragun T, Ishii K, Suzuki H, Tanaka A, Yanase Y, et al. Elevated serum IgE against MGL_1304 in patients with atopic dermatitis and cholinergic urticaria. Allergol Int. 2014;63(1):83\u201393.","journal-title":"Allergol Int"},{"issue":"2","key":"728_CR35","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/j.alit.2019.09.003","volume":"69","author":"Y Oda","year":"2020","unstructured":"Oda Y, Washio K, Fukunaga A, Imamura S, Hatakeyama M, Ogura K, et al. Clinical utility of the basophil activation test in the diagnosis of sweat allergy. Allergol Int. 2020;69(2):261\u20137.","journal-title":"Allergol Int"},{"issue":"8463","key":"728_CR36","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/S0140-6736(85)90905-5","volume":"2","author":"WB Shelley","year":"1985","unstructured":"Shelley WB, Shelley ED. Adrenergic urticaria: a new form of stress-induced hives. Lancet. 1985;2(8463):1031\u20133.","journal-title":"Lancet"},{"issue":"2","key":"728_CR37","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.alit.2017.10.007","volume":"67","author":"T Fukumoto","year":"2018","unstructured":"Fukumoto T, Ogura K, Fukunaga A, Nishigori C. Aquagenic urticaria: severe extra-cutaneous symptoms following cold water exposure. Allergol Int. 2018;67(2):295\u20137.","journal-title":"Allergol Int"},{"issue":"4","key":"728_CR38","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/0091-6749(81)90158-5","volume":"68","author":"AP Kaplan","year":"1981","unstructured":"Kaplan AP, Natbony SF, Tawil AP, Fruchter L, Foster M. Exercise-induced anaphylaxis as a manifestation of cholinergic urticaria. J Allergy Clin Immunol. 1981;68(4):319\u201324.","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"728_CR39","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1111\/j.1346-8138.1997.tb02770.x","volume":"24","author":"T Kato","year":"1997","unstructured":"Kato T, Komatsu H, Tagami H. Exercise-induced urticaria and angioedema: reports of two cases. J Dermatol. 1997;24(3):189\u201392.","journal-title":"J Dermatol"},{"issue":"5","key":"728_CR40","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1046\/j.1365-2133.2000.03845.x","volume":"143","author":"E Itakura","year":"2000","unstructured":"Itakura E, Urabe K, Yasumoto S, Nakayama J, Furue M. Cholinergic urticaria associated with acquired generalized hypohidrosis: report of a case and review of the literature. Br J Dermatol. 2000;143(5):1064\u20136.","journal-title":"Br J Dermatol"},{"issue":"3","key":"728_CR41","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1001\/archderm.1969.01610270033007","volume":"100","author":"DM Kay","year":"1969","unstructured":"Kay DM, Maibach HI. Pruritus and acquired anhidrosis: two unusual cases. Arch Dermatol. 1969;100(3):291\u20133.","journal-title":"Arch Dermatol"},{"issue":"9","key":"728_CR42","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1111\/1346-8138.12926","volume":"42","author":"M Honma","year":"2015","unstructured":"Honma M, Iinuma S, Kanno K, Komatsu S, Minami-Hori M, Ishida-Yamamoto A. Correlation of disease activity and serum level of carcinoembryonic antigen in acquired idiopathic generalized anhidrosis: a case report. J Dermatol. 2015;42(9):900\u20132.","journal-title":"J Dermatol"},{"issue":"6","key":"728_CR43","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/0091-6749(75)90078-0","volume":"55","author":"AP Kaplan","year":"1975","unstructured":"Kaplan AP, Gray L, Shaff RE, Horakova Z, Beaven MA. In vivo studies of mediator release in cold urticaria and cholinergic urticaria. J Allergy Clin Immunol. 1975;55(6):394\u2013402.","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"728_CR44","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/0091-6749(80)90114-1","volume":"66","author":"NA Soter","year":"1980","unstructured":"Soter NA, Wasserman SI. Physical urticaria\/angioedema: an experimental model of mast cell activation in humans. J Allergy Clin Immunol. 1980;66(5):358\u201365.","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"728_CR45","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/0091-6749(89)90008-0","volume":"83","author":"SP McClean","year":"1989","unstructured":"McClean SP, Arreaza EE, Lett-Brown MA, Grant JA. Refractory cholinergic urticaria successfully treated with ketotifen. J Allergy Clin Immunol. 1989;83(4):738\u201341.","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"728_CR46","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1016\/j.jaci.2016.05.026","volume":"138","author":"K Koch","year":"2016","unstructured":"Koch K, Weller K, Werner A, Maurer M, Altrichter S. Antihistamine updosing reduces disease activity in patients with difficult-to-treat cholinergic urticaria. J Allergy Clin Immunol. 2016;138(5):1483-5.e9.","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"728_CR47","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.ijwd.2020.12.011","volume":"7","author":"AT Young","year":"2021","unstructured":"Young AT, Yedidi RS, Raffi J, McCalmont TH, North J, Brinker A, et al. Idiopathic pure sudomotor failure: a review and two cases. Int J Womens Dermatol. 2021;7(3):276\u20139.","journal-title":"Int J Womens Dermatol."},{"issue":"5","key":"728_CR48","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/jid.1953.107","volume":"21","author":"MB Sulzberger","year":"1953","unstructured":"Sulzberger MB, Harrmann F, Borota A, Strauss MB. Studies of sweating. VI. On the urticariogenic properties of human sweat. J Invest Dermatol. 1953;21(5):293\u2013303.","journal-title":"J Invest Dermatol"},{"key":"728_CR49","first-page":"83","volume":"144","author":"K Adachi","year":"1989","unstructured":"Adachi K, Aoki T. IgE antibody to sweat in atopic dermatitis. Acta Derm Venereol Suppl (Stockh). 1989;144:83\u20137.","journal-title":"Acta Derm Venereol Suppl (Stockh)."},{"issue":"5","key":"728_CR50","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1080\/000155502320624050","volume":"82","author":"M Hide","year":"2002","unstructured":"Hide M, Tanaka T, Yamamura Y, Koro O, Yamamoto S. IgE-mediated hypersensitivity against human sweat antigen in patients with atopic dermatitis. Acta Derm Venereol. 2002;82(5):335\u201340.","journal-title":"Acta Derm Venereol"},{"issue":"6","key":"728_CR51","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1016\/j.jid.2017.11.040","volume":"138","author":"K Yamaga","year":"2018","unstructured":"Yamaga K, Murota H, Tamura A, Miyata H, Ohmi M, Kikuta J, et al. Claudin-3 loss causes leakage of sweat from the sweat gland to contribute to the pathogenesis of atopic dermatitis. J Invest Dermatol. 2018;138(6):1279\u201387.","journal-title":"J Invest Dermatol"},{"issue":"1","key":"728_CR52","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.alit.2020.05.006","volume":"70","author":"Y Tokura","year":"2021","unstructured":"Tokura Y. Direct and indirect action modes of acetylcholine in cholinergic urticaria. Allergol Int. 2021;70(1):39\u201344.","journal-title":"Allergol Int"},{"issue":"3","key":"728_CR53","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1159\/000057877","volume":"204","author":"H Kobayashi","year":"2002","unstructured":"Kobayashi H, Aiba S, Yamagishi T, Tanita M, Hara M, Saito H, et al. Cholinergic urticaria, a new pathogenic concept: hypohidrosis due to interference with the delivery of sweat to the skin surface. Dermatology. 2002;204(3):173\u20138.","journal-title":"Dermatology"},{"issue":"4","key":"728_CR54","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1159\/000096205","volume":"213","author":"NK Rho","year":"2006","unstructured":"Rho NK. Cholinergic urticaria and hypohidrosis: a clinical reappraisal. Dermatology. 2006;213(4):357\u20138.","journal-title":"Dermatology"},{"issue":"6","key":"728_CR55","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1111\/j.1365-2133.2009.09113.x","volume":"160","author":"A Fukunaga","year":"2009","unstructured":"Fukunaga A, Horikawa T, Sato M, Nishigori C. Acquired idiopathic generalized anhidrosis: possible pathogenic role of mast cells. Br J Dermatol. 2009;160(6):1337\u201340.","journal-title":"Br J Dermatol"},{"issue":"9","key":"728_CR56","doi-asserted-by":"publisher","first-page":"e314","DOI":"10.1111\/1346-8138.15474","volume":"47","author":"T Fukumoto","year":"2020","unstructured":"Fukumoto T, Sugiyama M, Fukunaga A, Nishigori C. Acquired idiopathic partial anhidrosis successfully treated with adapalene gel. J Dermatol. 2020;47(9):e314\u20135.","journal-title":"J Dermatol"},{"issue":"4","key":"728_CR57","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1111\/j.1365-2133.2010.09658.x","volume":"162","author":"S Nakamizo","year":"2010","unstructured":"Nakamizo S, Miyachi Y, Kabashima K. A case of cholinergic urticaria associated with acquired generalized hypohidrosis and abnormal neurological findings: association with incomplete Ross syndrome? Br J Dermatol. 2010;162(4):903\u20135.","journal-title":"Br J Dermatol"},{"issue":"8329","key":"728_CR58","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/S0140-6736(83)91386-7","volume":"1","author":"WB Shelley","year":"1983","unstructured":"Shelley WB, Shelley ED, Ho AK. Cholinergic urticaria: acetylcholine-receptor-dependent immediate-type hypersensitivity reaction to copper. Lancet. 1983;1(8329):843\u20136.","journal-title":"Lancet"},{"issue":"8","key":"728_CR59","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1111\/jdv.13390","volume":"30","author":"M Honma","year":"2016","unstructured":"Honma M, Iinuma S, Kanno K, Komatsu S, Minami-Hori M, Iizuka H, et al. Serum carcinoembryonic antigen (CEA) as a clinical marker in acquired idiopathic generalized anhidrosis: a close correlation between serum CEA level and disease activity. J Eur Acad Dermatol Venereol. 2016;30(8):1379\u201383.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"7","key":"728_CR60","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1111\/1346-8138.13785","volume":"44","author":"T Munetsugu","year":"2017","unstructured":"Munetsugu T, Fujimoto T, Satoh T, Nakazato Y, Ohshima Y, Asahina M, et al. Evaluation of the correlation between severity of acquired idiopathic generalized anhidrosis and quality of life scores. J Dermatol. 2017;44(7):747\u201352.","journal-title":"J Dermatol"},{"issue":"5","key":"728_CR61","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2340\/0001555560373380","volume":"60","author":"L Illig","year":"1980","unstructured":"Illig L, Paul E, Bruck K, Schwennicke HP. Experimental investigations on the trigger mechanism of the generalized type of heat and cold urticaria by means of a climatic chamber. Acta Derm Venereol. 1980;60(5):373\u201380.","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"728_CR62","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/j.1365-2133.1978.tb07332.x","volume":"98","author":"CA Commens","year":"1978","unstructured":"Commens CA, Greaves MW. Tests to establish the diagnosis in cholinergic urticaria. Br J Dermatol. 1978;98(1):47\u201351.","journal-title":"Br J Dermatol"},{"issue":"2","key":"728_CR63","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.jdermsci.2014.04.007","volume":"75","author":"S Altrichter","year":"2014","unstructured":"Altrichter S, Salow J, Ardelean E, Church MK, Werner A, Maurer M. Development of a standardized pulse-controlled ergometry test for diagnosing and investigating cholinergic urticaria. J Dermatol Sci. 2014;75(2):88\u201393.","journal-title":"J Dermatol Sci"},{"issue":"12","key":"728_CR64","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1111\/jdv.13765","volume":"30","author":"S Altrichter","year":"2016","unstructured":"Altrichter S, Koch K, Church MK, Maurer M. Atopic predisposition in cholinergic urticaria patients and its implications. J Eur Acad Dermatol Venereol. 2016;30(12):2060\u20135.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"728_CR65","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1111\/bjd.14543","volume":"175","author":"E Pezzolo","year":"2016","unstructured":"Pezzolo E, Peroni A, Gisondi P, Girolomoni G. Heat urticaria: a revision of published cases with an update on classification and management. Br J Dermatol. 2016;175(3):473\u20138.","journal-title":"Br J Dermatol"},{"issue":"6","key":"728_CR66","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/S1081-1206(10)63071-2","volume":"80","author":"KV Luong","year":"1998","unstructured":"Luong KV, Nguyen LT. Aquagenic urticaria: report of a case and review of the literature. Ann Allergy Asthma Immunol. 1998;80(6):483\u20135.","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"3","key":"728_CR67","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2340\/00015555-0435","volume":"88","author":"A Chedraoui","year":"2008","unstructured":"Chedraoui A, Uthman I, Abbas O, Ghosn S. Adrenergic urticaria in a patient with anti-double-stranded DNA antibodies. Acta Derm Venereol. 2008;88(3):263\u20136.","journal-title":"Acta Derm Venereol"},{"issue":"6","key":"728_CR68","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1111\/1346-8138.12855","volume":"42","author":"Y Kawakami","year":"2015","unstructured":"Kawakami Y, Gokita M, Fukunaga A, Nishigori C. Refractory case of adrenergic urticaria successfully treated with clotiazepam. J Dermatol. 2015;42(6):635\u20137.","journal-title":"J Dermatol"},{"key":"728_CR69","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.alit.2022.01.003","volume":"71","author":"S Takahagi","year":"2022","unstructured":"Takahagi S, Okamoto M, Ishii K, Tanaka A, Mizuno H, Harada N, et al. Clinical and histological characterization of transient dermal pain triggered by sweating stimuli. Allergol Int. 2022;71:362\u201372.","journal-title":"Allergol Int"},{"issue":"4","key":"728_CR70","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1159\/000246281","volume":"193","author":"T Zuberbier","year":"1996","unstructured":"Zuberbier T, Munzberger C, Haustein U, Trippas E, Burtin B, Mariz SD, et al. Double-blind crossover study of high-dose cetirizine in cholinergic urticaria. Dermatology. 1996;193(4):324\u20137.","journal-title":"Dermatology"},{"issue":"10","key":"728_CR71","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1046\/j.1365-4362.2003.02010.x","volume":"42","author":"Y Tsunemi","year":"2003","unstructured":"Tsunemi Y, Ihn H, Saeki H, Tamaki K. Cholinergic urticaria successfully treated with scopolamine butylbromide. Int J Dermatol. 2003;42(10):850.","journal-title":"Int J Dermatol"},{"issue":"2","key":"728_CR72","doi-asserted-by":"publisher","first-page":"217","DOI":"10.7205\/MILMED.173.2.217","volume":"173","author":"JH Feinberg","year":"2008","unstructured":"Feinberg JH, Toner CB. Successful treatment of disabling cholinergic urticaria. Mil Med. 2008;173(2):217\u201320.","journal-title":"Mil Med"},{"issue":"6","key":"728_CR73","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1111\/bjd.12200","volume":"168","author":"A Sheraz","year":"2013","unstructured":"Sheraz A, Halpern S. Cholinergic urticaria responding to botulinum toxin injection for axillary hyperhidrosis. Br J Dermatol. 2013;168(6):1369\u201370.","journal-title":"Br J Dermatol"},{"issue":"3","key":"728_CR74","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1001\/jamadermatol.2013.8705","volume":"150","author":"M Metz","year":"2014","unstructured":"Metz M, Ohanyan T, Church MK, Maurer M. Retreatment with omalizumab results in rapid remission in chronic spontaneous and inducible urticaria. JAMA Dermatol. 2014;150(3):288\u201390.","journal-title":"JAMA Dermatol"},{"issue":"2","key":"728_CR75","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1111\/j.1398-9995.2007.01591.x","volume":"63","author":"M Metz","year":"2008","unstructured":"Metz M, Bergmann P, Zuberbier T, Maurer M. Successful treatment of cholinergic urticaria with anti-immunoglobulin E therapy. Allergy. 2008;63(2):247\u20139.","journal-title":"Allergy"},{"key":"728_CR76","doi-asserted-by":"publisher","DOI":"10.3109\/9781420077858-10","author":"RA Sabroe","year":"2009","unstructured":"Sabroe RA. Failure of omalizumab in cholinergic urticaria. Clin Exp Dermatol. 2009. https:\/\/doi.org\/10.3109\/9781420077858-10.","journal-title":"Clin Exp Dermatol"},{"issue":"2","key":"728_CR77","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.jaci.2018.08.050","volume":"143","author":"S Altrichter","year":"2019","unstructured":"Altrichter S, Chuamanochan M, Knoth H, Asady A, Ohanyan T, Metz M, et al. Real-life treatment of cholinergic urticaria with omalizumab. J Allergy Clin Immunol. 2019;143(2):788-91.e8.","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"728_CR78","doi-asserted-by":"publisher","first-page":"894","DOI":"10.4168\/aair.2020.12.5.894","volume":"12","author":"JH Kim","year":"2020","unstructured":"Kim JH, Park HS, Ye YM, Shin YS, Kang HR, Chung SJ, et al. Omalizumab treatment in patients with cholinergic urticaria: a real-world retrospective study in Korea. Allergy Asthma Immunol Res. 2020;12(5):894\u20136.","journal-title":"Allergy Asthma Immunol Res"},{"issue":"3","key":"728_CR79","doi-asserted-by":"publisher","first-page":"277","DOI":"10.2332\/allergolint.10-OA-0269","volume":"60","author":"T Kozaru","year":"2011","unstructured":"Kozaru T, Fukunaga A, Taguchi K, Ogura K, Nagano T, Oka M, et al. Rapid desensitization with autologous sweat in cholinergic urticaria. Allergol Int. 2011;60(3):277\u201381.","journal-title":"Allergol Int"},{"issue":"4","key":"728_CR80","doi-asserted-by":"publisher","DOI":"10.1111\/dth.13647","volume":"33","author":"T Minowa","year":"2020","unstructured":"Minowa T, Sumikawa Y, Kan Y, Kamiya T, Uhara H. Regular sweating activities for the treatment of cholinergic urticaria with or without acquired idiopathic generalized anhidrosis. Dermatol Ther. 2020;33(4): e13647.","journal-title":"Dermatol Ther"},{"issue":"2","key":"728_CR81","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1111\/j.1365-2133.2012.11112.x","volume":"168","author":"Y Ohshima","year":"2013","unstructured":"Ohshima Y, Yanagishita T, Ito K, Tamada Y, Nishimura N, Inukai Y, et al. Treatment of patients with acquired idiopathic generalized anhidrosis. Br J Dermatol. 2013;168(2):430\u20132.","journal-title":"Br J Dermatol"},{"issue":"3","key":"728_CR82","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1111\/1346-8138.15666","volume":"48","author":"T Iida","year":"2021","unstructured":"Iida T, Nakamura M, Inazawa M, Munetsugu T, Nishida M, Fujimoto T, et al. Prognosis after steroid pulse therapy and seasonal effect in acquired idiopathic generalized anhidrosis. J Dermatol. 2021;48(3):271\u20138.","journal-title":"J Dermatol"},{"issue":"6","key":"728_CR83","doi-asserted-by":"publisher","first-page":"723","DOI":"10.2340\/00015555-1820","volume":"94","author":"A Suma","year":"2014","unstructured":"Suma A, Murota H, Kitaba S, Yamaoka T, Kato K, Matsui S, et al. Idiopathic pure sudomotor failure responding to oral antihistamine with sweating activities. Acta Derm Venereol. 2014;94(6):723\u20134.","journal-title":"Acta Derm Venereol"},{"issue":"4","key":"728_CR84","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1684\/ejd.2019.3573","volume":"29","author":"N Kubota","year":"2019","unstructured":"Kubota N, Furuta JI, Onizawa S, Saito A, Nakamura Y, Ishitsuka Y, et al. Oral pilocarpine alleviates the symptoms of acquired idiopathic generalised anhidrosis. Eur J Dermatol. 2019;29(4):422\u20133.","journal-title":"Eur J Dermatol"},{"issue":"2","key":"728_CR85","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1111\/1346-8138.15141","volume":"47","author":"Y Ihibashi-Kunimi","year":"2020","unstructured":"Ihibashi-Kunimi Y, Imafuku S. Cholinergic urticaria with hypohidrosis successfully treated with omalizumab. J Dermatol. 2020;47(2):e47\u20138.","journal-title":"J Dermatol"}],"container-title":["American Journal of Clinical Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-022-00728-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40257-022-00728-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-022-00728-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T11:07:18Z","timestamp":1744715238000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40257-022-00728-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,15]]},"references-count":85,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["728"],"URL":"https:\/\/doi.org\/10.1007\/s40257-022-00728-6","relation":{},"ISSN":["1175-0561","1179-1888"],"issn-type":[{"value":"1175-0561","type":"print"},{"value":"1179-1888","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,15]]},"assertion":[{"value":"26 August 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This work was supported in part by Japan Society for the Promotion of Science KAKENHI (Grant number 20K08651).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"AF has received fees for speaking from Novartis, Sanofi, Takeda, Tanabe-Mitsubishi, Kyowa-Kirin, Kyorin, Kaken, and Taiho. AF has also received funds for sponsored\/joint research from Novartis and Taiho. KW has received fees for speaking from Sanofi, Maruho, Novartis, Taiho, Tanabe-Mitsubishi, Kyowa-Kirin, and AbbVie. YO has received fees for speaking from Janssen Pharm. The other authors have no conflicts of interest that are directly relevant to the content of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest\/competing interests"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Consent was obtained from the patient in the presented photograph.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"AF had full access to all the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. YO, SI, MM, and TF drafted the manuscript. KW supervised the conduct of this study. All authors reviewed the manuscript draft and revised it critically for intellectual content. All authors approved the final version of the manuscript to be published.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}